Verapamil for type 1 diabetes
Recent research has shed light on a potential new avenue to reduce insulin requirements for people with type 1 diabetes.
An estimated 1.2 million Australians...
Pharmacists on the front line: Approaches to mental illness
Australia’s run of catastrophic summer bushfires followed by the COVID-19 pandemic has taken a grim toll on the nation’s mental health.
Highlights from WA’s Annual Therapeutic Update
Western Australian pharmacists were treated to a program chock-full of clinical advice for grappling with some of today’s key health issues at PSA’s 2021 WA Annual Therapeutic Update held on 8 May.
Pharmacists honoured at annual awards
Pharmacists in Queensland and Tasmania have been recognised for their contributions to the health of the community, with awards presented at two events at...
Chronic lymphocytic leukaemia and the pharmacist
The management of chronic lymphocytic leukaemia has changed dramatically in the last decade with the introduction of novel oral immune-targeted therapies. There are increasing opportunities for pharmacists to contribute to the multidisciplinary care of patients with CLL to ensure medicine safety and best patient outcomes.
Sepsis: recognition and management
Sepsis is defined as life-threatening organ dysfunction caused by a dysregulated host response to infection. It is a medical emergency which, if left untreated, progresses to septic shock, multi-organ failure and death.














